Literature DB >> 24947674

Research resource: comparison of gene profiles from wild-type ERα and ERα hinge region mutants.

Katherine A Burns1, Yin Li, Liwen Liu, Kenneth S Korach.   

Abstract

We showed previously that the hinge region of estrogen receptor (ER) α is involved in mediating its actions. The hinge 1 (H1) ERα mutant has disrupted nuclear localization and has lost interaction with c-JUN, but retains estrogen response element (ERE)-mediated functions. The hinge 2 + nuclear export sequence (H2NES) ERα mutant does not maintain nuclear translocation with hormone and no longer activates ERE target genes but does retain a nongenomic, nonnuclear, rapid-action response. Herein, we used the human endometrial cancer Ishikawa stable cell lines (Ishikawa/vector, Ishikawa/wild-type [WT] ERα, Ishikawa/H1 ERα, or Ishikawa/H2NES ERα) to characterize the biological activities of these 2 ERα hinge region mutants. We confirmed by confocal microscopy increased cytoplasmic ERα in the H1 ERα cell line and full cytoplasmic ERα localization in the H2NES ERα cell line. Luciferase assays using the 3xERE reporter showed activation of H1 ERα and H2NES ERα by estradiol (E2) treatment, but using the endogenous pS2 reporter, luciferase activity was only seen with the H1 ERα cell line. Examining cell proliferation revealed that only the WT ERα and H1 ERα cell lines increased proliferation after treatment. Using microarrays, we found that WT ERα and H1 ERα cluster together, whereas vector and H2NES ERα are most similar and cluster independently of E2 treatment. These studies revealed that the nongenomic activities of ERα are unable to mediate proliferative changes or the transcriptional profile after treatment and demonstrate the importance of genomic action for ERα/E2-mediated responses with the nongenomic actions of ERα being complementary to elicit the full biological actions of ERα.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24947674      PMCID: PMC4116590          DOI: 10.1210/me.2014-1122

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  44 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

Review 2.  The Ishikawa cells from birth to the present.

Authors:  Masato Nishida
Journal:  Hum Cell       Date:  2002-09       Impact factor: 4.174

Review 3.  Estrogen modulation of endothelial nitric oxide synthase.

Authors:  Ken L Chambliss; Philip W Shaul
Journal:  Endocr Rev       Date:  2002-10       Impact factor: 19.871

4.  Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway.

Authors:  M Jakacka; M Ito; J Weiss; P Y Chien; B D Gehm; J L Jameson
Journal:  J Biol Chem       Date:  2001-01-18       Impact factor: 5.157

Review 5.  Estrogen receptor pathways to AP-1.

Authors:  P J Kushner; D A Agard; G L Greene; T S Scanlan; A K Shiau; R M Uht; P Webb
Journal:  J Steroid Biochem Mol Biol       Date:  2000-11-30       Impact factor: 4.292

6.  Characterization of the physical interaction between estrogen receptor alpha and JUN proteins.

Authors:  C Teyssier; K Belguise; F Galtier; D Chalbos
Journal:  J Biol Chem       Date:  2001-07-26       Impact factor: 5.157

7.  Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains.

Authors:  R Métivier; G Penot; G Flouriot; F Pakdel
Journal:  Mol Endocrinol       Date:  2001-11

Review 8.  Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions.

Authors:  S Safe
Journal:  Vitam Horm       Date:  2001       Impact factor: 3.421

9.  Differences in the abilities of estrogen receptors to integrate activation functions are critical for subtype-specific transcriptional responses.

Authors:  Ping Yi; Sumedha Bhagat; Russell Hilf; Robert A Bambara; Mesut Muyan
Journal:  Mol Endocrinol       Date:  2002-08

10.  An estrogen receptor (ER)alpha deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo.

Authors:  Monika Jakacka; Masafumi Ito; Fred Martinson; Toshio Ishikawa; Eun Jig Lee; J Larry Jameson
Journal:  Mol Endocrinol       Date:  2002-10
View more
  8 in total

Review 1.  Experimental models for evaluating non-genomic estrogen signaling.

Authors:  Megan L Stefkovich; Yukitomo Arao; Katherine J Hamilton; Kenneth S Korach
Journal:  Steroids       Date:  2017-11-06       Impact factor: 2.668

Review 2.  Endocrine disruption through membrane estrogen receptors and novel pathways leading to rapid toxicological and epigenetic effects.

Authors:  Cheryl S Rosenfeld; Paul S Cooke
Journal:  J Steroid Biochem Mol Biol       Date:  2018-11-19       Impact factor: 4.292

Review 3.  Estrogen Hormone Biology.

Authors:  Katherine J Hamilton; Sylvia C Hewitt; Yukitomo Arao; Kenneth S Korach
Journal:  Curr Top Dev Biol       Date:  2017-02-03       Impact factor: 4.897

4.  Aryl hydrocarbon receptor (AhR) regulates adipocyte differentiation by assembling CRL4B ubiquitin ligase to target PPARγ for proteasomal degradation.

Authors:  Hao Dou; Yuyao Duan; Xiaohui Zhang; Qian Yu; Qian Di; Yu Song; Peishan Li; Yaoqin Gong
Journal:  J Biol Chem       Date:  2019-10-25       Impact factor: 5.157

5.  Ubiquitin Ligase NEDD4 Regulates PPARγ Stability and Adipocyte Differentiation in 3T3-L1 Cells.

Authors:  Jing Jing Li; Ruishan Wang; Rati Lama; Xinjiang Wang; Z Elizabeth Floyd; Edwards A Park; Francesca-Fang Liao
Journal:  Sci Rep       Date:  2016-12-05       Impact factor: 4.379

Review 6.  Comparing the rules of engagement of androgen and glucocorticoid receptors.

Authors:  Frank Claessens; Steven Joniau; Christine Helsen
Journal:  Cell Mol Life Sci       Date:  2017-02-06       Impact factor: 9.261

7.  Differential in Vitro Biological Action, Coregulator Interactions, and Molecular Dynamic Analysis of Bisphenol A (BPA), BPAF, and BPS Ligand-ERα Complexes.

Authors:  Yin Li; Lalith Perera; Laurel A Coons; Katherine A Burns; J Tyler Ramsey; Katherine E Pelch; René Houtman; Rinie van Beuningen; Christina T Teng; Kenneth S Korach
Journal:  Environ Health Perspect       Date:  2018-01-31       Impact factor: 9.031

8.  R269C variant of ESR1: high prevalence and differential function in a subset of pancreatic cancers.

Authors:  Tomer Boldes; Keren Merenbakh-Lamin; Shani Journo; Eliya Shachar; Doron Lipson; Adva Yeheskel; Metsada Pasmanik-Chor; Tami Rubinek; Ido Wolf
Journal:  BMC Cancer       Date:  2020-06-08       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.